Glaukos says Phase 4 trial shows iDose TR plus cataract surgery cuts mean diurnal IOP more than surgery alone
GKOS•Glaukos reported positive topline Phase 4 trial results, with iDose TR plus cataract surgery showing better eye-pressure control than surgery alone. Through three months, safety appeared favorable, with no treatment-related serious corneal events reported.
1. Trial results
Glaukos reported positive topline results from a Phase 4 trial of iDose TR used during cataract surgery. Patients receiving iDose TR with surgery showed better eye-pressure control than patients who had cataract surgery alone. Through three months, the safety profile appeared favorable, with no treatment-related serious corneal events reported.
